Spots Global Cancer Trial Database for oxaliplatin
Every month we try and update this database with for oxaliplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) | NCT05564403 | Recurrent Bilia... Recurrent Dista... Recurrent Gallb... Recurrent Intra... Stage III Dista... Stage III Hilar... Stage III Intra... Stage IV Distal... Stage IV Hilar ... Stage IV Intrah... Unresectable Bi... Unresectable Di... Unresectable Ga... Unresectable In... | Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Leucovorin Calc... Magnetic Resona... Multigated Acqu... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma | NCT00861783 | Hepatoma Advanced Solid ... | irinotecan and ... oxaliplatin and... | 18 Years - | Traws Pharma, Inc. | |
| A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors | NCT06139211 | Advanced Solid ... | JS015 Toripalimab Paclitaxel Irinotecan Capecitabine Oxaliplatin Bevacizumab Fluorouracil Leucovorin Gemcitabine Albumin-Bound P... | 18 Years - 75 Years | Shanghai Junshi Bioscience Co., Ltd. | |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | NCT00025337 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | bevacizumab oxaliplatin leucovorin calc... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | NCT04882241 | Gastric Cancer Gastroesophagea... | Pembrolizumab Placebo Cisplatin Capecitabine 5-fluorouracil Docetaxel Oxaliplatin Leucovorin | 18 Years - | Merck Sharp & Dohme LLC | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00492999 | Colorectal Canc... Metastatic Canc... | dexamethasone floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | NCT00016198 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | NCT02296671 | Esophagogastric... | Pemetrexed Oxaliplatin Leucovorin Fluorouracil Germline genoty... | 18 Years - | Washington University School of Medicine | |
| Oxaliplatin in Treating Children With Advanced Solid Tumors | NCT00005844 | Unspecified Chi... | oxaliplatin | - 21 Years | St. Jude Children's Research Hospital | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama | NCT04627363 | Hepatocellular ... Bevacizumab Liver Neoplasms Toripalimab Oxaliplatin | Hepatic arteria... Bevacizumab Toripalimab | 18 Years - 75 Years | Sun Yat-sen University | |
| XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy | NCT02350686 | Biliary Tract C... | capecitabine oxaliplatin | 18 Years - | Samsung Medical Center | |
| Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer | NCT04518280 | Locally Advance... | PD-1 antibody Capecitabine Oxaliplatin Short-course ra... | 18 Years - 70 Years | Fudan University | |
| Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer | NCT02954536 | Esophageal Canc... Gastric Cancer | pembrolizumab trastuzumab capecitabine cisplatin Oxaliplatin 5-Fluorouracil | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE) | NCT05646511 | Locally Advance... | SCRT CAPOX CAPOXIRI | 18 Years - | National Cancer Center Hospital East | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00613080 | Colorectal Canc... | capecitabine oxaliplatin resection radiation thera... FOLFOX | 18 Years - | Radiation Therapy Oncology Group | |
| Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers | NCT03515941 | Gastrointestina... | Oxaliplatin Capecitabine Leucovorin 5-fluorouracil radiation | 18 Years - | Baylor College of Medicine | |
| Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL. | NCT01670370 | Diffuse Large B... | R-GemOx | 60 Years - | The First Affiliated Hospital with Nanjing Medical University | |
| Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | NCT03812770 | Hepatocellular ... | Sorafenib HAIC of FOLFOX HAIC of OXA | 18 Years - 75 Years | Sun Yat-sen University | |
| A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | NCT04408638 | Diffuse Large B... | Obinutuzumab Glofitamab Rituxumab Tocilizumab Gemcitabine Oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00049101 | Colorectal Canc... | erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC | NCT03222089 | Metastatic Colo... | Irinotecan Oxaliplatin Levoleucovorin 5-FU GM-CSF IL-2 | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | NCT04703101 | Locally Advance... Rectal Adenocar... Stage II Rectal... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Capecitabine Fluorouracil Intensity-Modul... Leucovorin Oxaliplatin Quality-of-Life... Surveillance Total Mesorecta... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | NCT03000374 | Rectal Cancer | Panitumumab 5Fluorouracil Oxaliplatin Leucovorin | 18 Years - 74 Years | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | NCT00537823 | Colorectal Canc... Metastases | Cetuximab Bevacizumab Leucovorin Oxaliplatin Fluorouracil | 18 Years - | Washington University School of Medicine | |
| FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer | NCT02063529 | Metastatic Colo... | FOLFOXIRI + Cet... FOLFOXIRI | 18 Years - 65 Years | Sun Yat-sen University | |
| Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | NCT00062426 | Colorectal Canc... | bevacizumab capecitabine fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer | NCT03745170 | Gastric Cancer | Sintilimab Oxaliplatin Capecitabine placebo | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer | NCT02497157 | Metastatic Colo... | Oxaliplatin (L-... Irinotecan hydr... Continuous intr... Levofolinate ca... Bevacizumab (Bm... | 20 Years - 70 Years | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | |
| Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00080951 | Colorectal Canc... | fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer | NCT06225622 | Metastatic Colo... | Irinotecan Lipo... Oxaliplatin 5-FU LV Bevacizumab Cetuximab | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | NCT00057863 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Recurrent Cervi... Stage IVA Cervi... Stage IVB Cervi... | Paclitaxel Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma | NCT03585673 | Esophagus Squam... Metastatic Canc... | Docetaxel-PM Oxaliplatin | 18 Years - | Dong-A University Hospital | |
| Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | NCT04488159 | Colon Cancer St... | Capecitabine Oxaliplatin Fluorouracil Leucovorin Immunoscore® as... Physical exerci... | 18 Years - 100 Years | Medical University of Vienna | |
| SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer | NCT04417699 | Rectal Cancer | TAS 102 Oxaliplatin | 18 Years - | Providence Health & Services | |
| Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | NCT00096278 | Colon Adenocarc... Stage IIA Colon... Stage IIB Colon... Stage IIC Colon... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... | Bevacizumab Fluorouracil Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | NCT02539537 | Pancreatic Canc... Carcinoma | Gemcitabine Folinic Acid 5-Fluoro-uracil Oxaliplatin Irinotecan L-folinic | 18 Years - | UNICANCER | |
| Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | NCT00571740 | Colorectal Canc... | bevacizumab cetuximab fluorouracil leucovorin calc... oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | NCT00005839 | Unspecified Adu... | capecitabine oxaliplatin | 18 Years - | City of Hope Medical Center | |
| A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer | NCT00642603 | Colorectal Canc... | capecitabine [X... capecitabine [X... bevacizumab [Av... oxaliplatin irinotecan | 18 Years - | Hoffmann-La Roche | |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | NCT00008281 | Colorectal Canc... | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer | NCT02842580 | Colorectal Neop... | 5 FLUOROURACYL acide folinique irinotecan Oxaliplatin capécitabine bevacizumab | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | NCT04488159 | Colon Cancer St... | Capecitabine Oxaliplatin Fluorouracil Leucovorin Immunoscore® as... Physical exerci... | 18 Years - 100 Years | Medical University of Vienna | |
| Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer | NCT05479240 | Immunotherapy | Tislelizumab Capecitabine oxaliplatin short-range rad... | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | NCT01231399 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Stage IV Esopha... Stage IV Gastri... | fluorouracil leucovorin calc... oxaliplatin everolimus laboratory biom... immunohistochem... microarray anal... | 19 Years - | City of Hope Medical Center | |
| Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies | NCT04361708 | Pancreatic Aden... Gastroesophagea... Adenocarcinoma | Oxaliplatin Docetaxel Leucovorin Irinotecan 5-Fluorouracil | 18 Years - | University of Chicago | |
| Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma | NCT04097028 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... | Trifluridine an... Oxaliplatin | 18 Years - | Roswell Park Cancer Institute | |
| Oxaliplatin in Rectal Cancer | NCT00259363 | Rectal Neoplasm... | Oxaliplatin | 18 Years - 80 Years | Sanofi | |
| Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | NCT00268411 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient | NCT01955629 | Colorectal Canc... | Aflibercept AVE... Oxaliplatin Capecitabine | 18 Years - | Sanofi | |
| Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | NCT00323583 | Adenocarincoma ... Stage III Pancr... Stage IVA Pancr... Stage IVB Pancr... | paclitaxel oxaliplatin leucovorin 5-fluorouracil glutathione calcium and mag... Chemotherapy Chemoprotection Complementary a... | 18 Years - 65 Years | Seattle Cancer Treatment and Wellness Center | |
| Gemox as First and Second Line Therapy in Unknown Primary Cancer | NCT00353145 | Unknown Primary... | Gemcitabine (Ge... Oxaliplatin Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | NCT02715531 | Solid Tumor | 5-FU Atezolizumab Bevacizumab Gemcitabine Leucovorin Nab-Paclitaxel Oxaliplatin Capecitabine Cisplatin | 18 Years - | Hoffmann-La Roche | |
| Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | NCT00049101 | Colorectal Canc... | erlotinib hydro... fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer | NCT01442155 | Colorectal Canc... | Capecitabine Oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | NCT00200200 | Hepatic Metasta... Colon Cancer Rectal Cancer | Bevacizumab HAI... HAI plus system... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study | NCT02345460 | Pancreatic Aden... Poorly Differen... Resectable Panc... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Undifferentiate... | Irinotecan Hydr... Oxaliplatin Leucovorin Calc... Fluorouracil Laboratory Biom... | 18 Years - 75 Years | Case Comprehensive Cancer Center | |
| Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer | NCT00871169 | Pancreatic Canc... | Irinotecan, oxa... | 18 Years - | New Mexico Cancer Care Alliance | |
| Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma | NCT04150640 | Esophageal Aden... Gastric Adenoca... | Nal-IRI Oxaliplatin 5-FU Trastuzumab Pembrolizumab Nivolumab | 18 Years - | University of Wisconsin, Madison | |
| Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) | NCT04210115 | Esophageal Squa... Gastroesophagea... Esophageal Aden... | pembrolizumab placebo cisplatin 5-FU radiotherapy leucovorin levoleucovorin oxaliplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | NCT00008060 | Colorectal Canc... | FOLFIRI regimen FOLFOX regimen fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma | NCT03469557 | Esophageal Squa... | Tislelizumab Cisplatin 5-FU Oxaliplatin Capecitabine | 18 Years - 75 Years | BeiGene | |
| Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | NCT00068692 | Rectal Mucinous... Rectal Signet R... Recurrent Recta... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... Stage IVA Recta... Stage IVB Recta... | Radiotherapy Fluorouracil Leucovorin Calc... Oxaliplatin Irinotecan | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. | NCT00454636 | Gastric Cancer | Cisplatin Capecitabine Epirubicin Cisplatin Capecitabine Oxaliplatin Docetaxel Capecitabine | 18 Years - | Hoffmann-La Roche | |
| Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma | NCT00859469 | Mesothelioma | Oxaliplatin Gemcitabine | 18 Years - | Columbia University | |
| Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer | NCT00462501 | Colorectal Canc... | bevacizumab fluorouracil leucovorin calc... oxaliplatin conventional su... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions | NCT06313801 | Gastric Cancer | Docetaxel Oxaliplatin Calcium folinat... Fluorouracil Diagnostic lapa... dPIPAC ( The de... | 18 Years - 75 Years | Nizhny Novgorod Regional Clinical Oncology Center | |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | NCT00138177 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... Unspecified Adu... | oxaliplatin leucovorin calc... vorinostat fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer | NCT04982939 | Gastric Cancer Perioperative Sintilimab | Sintilimab S-1 Oxaliplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | NCT00217737 | Colon Mucinous ... Colon Signet Ri... Lynch Syndrome Stage IIA Colon... Stage IIB Colon... Stage IIC Colon... | Bevacizumab Fluorouracil Laboratory Biom... Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer | NCT00865189 | Rectal Cancer | Bevacizumab Oxaliplatin Folinic Acid 5-fluorouracil Preoperative Ra... Surgery | 18 Years - 75 Years | Hoffmann-La Roche | |
| PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer | NCT04301557 | DMMR Colorectal... MSI-H Colorecta... Locally Advance... | PD-1 Antibody Oxaliplatin Capecitabine External beam r... Total mesorecta... | 18 Years - 72 Years | Sun Yat-sen University | |
| GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | NCT00262808 | Colorectal Canc... | sargramostim fluorouracil leucovorin calc... oxaliplatin adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | University of Rochester | |
| A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade Large B-Cell Lymphoma | NCT04313608 | B-cell Lymphoma | Glofitamab Gemcitabine Oxaliplatin Mosunetuzumab Obinutuzumab Tocilizumab | 18 Years - | Hoffmann-La Roche | |
| Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | NCT00005077 | Unspecified Adu... | oxaliplatin | 18 Years - | City of Hope Medical Center | |
| Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | NCT00551759 | Esophageal Canc... | 5-Fluorouracil Oxaliplatin Cetuximab Docetaxel Surgery Radiotherapy | 18 Years - | Eastern Cooperative Oncology Group | |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | NCT04447352 | Gastric Cancer Gastroesophagea... | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Cisplatin | 18 Years - 75 Years | Krankenhaus Nordwest |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
